Efficacy/Safety Study of Glimepiride to Type 2 Diabetes Patients Based on Metformin And Basal Insulin Treatment
Status:
Completed
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
All the guidelines suggest that metformin as the basis of type 2 diabetes medication, and
evidence is sufficient.At the same time the basal insulin injection once a day are more and
more widely used in diabetes patients in China.
This study aims to evaluate the efficacy and safety of adding glimepiride to type 2 diabetes
patients with inadequate glycemic control with combined therapy of metformin and basal
insulin.